Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1982 Jan;69(1):45-9.

Failure of hydrocortisone to affect outcome in dengue shock syndrome

  • PMID: 7054760
Clinical Trial

Failure of hydrocortisone to affect outcome in dengue shock syndrome

Sumarmo et al. Pediatrics. 1982 Jan.

Abstract

Despite the absence of a clear-cut rationale for their use, corticosteroids are widely employed in the treatment of dengue shock syndrome. Previous comparative therapeutic trials have yielded contradictory results. Resolution of this therapeutic controversy has been attempted with a double-blind evaluation of the clinical effect of steroid administration in dengue shock syndrome. Placebo or a single dose of hydrocortisone hemisuccinate, 50 mg/kg of body weight, was administered randomly to 97 physiologically treated patients with dengue shock syndrome. The severity of disease on admission to the hospital and the effectiveness of treatment were quantified by a World Health Organization scoring system. The response to therapy as measured by mortality, duration of shock, and amount of replacement fluids required was virtually identical in 47 children who were and 50 children who were not treated with steroids. The comparison groups were composed of children similar in age, sex, and severity of illness. It is concluded that hydrocortisone is of no value in the treatment of dengue shock syndrome. Reliance should be placed on appropriate supportive and physiologic therapy.

PubMed Disclaimer

Similar articles

Cited by

  • Pediatric sepsis: challenges and adjunctive therapies.
    Hanna W, Wong HR. Hanna W, et al. Crit Care Clin. 2013 Apr;29(2):203-22. doi: 10.1016/j.ccc.2012.11.003. Epub 2013 Jan 3. Crit Care Clin. 2013. PMID: 23537672 Free PMC article. Review.
  • Is "rescue" therapy ethical in randomized controlled trials?
    Holubkov R, Dean JM, Berger J, Anand KJ, Carcillo J, Meert K, Zimmerman J, Newth C, Harrison R, Willson DF, Nicholson C; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network. Holubkov R, et al. Pediatr Crit Care Med. 2009 Jul;10(4):431-8. doi: 10.1097/PCC.0b013e318198bd13. Pediatr Crit Care Med. 2009. PMID: 19307815 Free PMC article. Review.
  • Corticosteroids for dengue - why don't they work?
    Nguyen TH, Nguyen TH, Vu TT, Farrar J, Hoang TL, Dong TH, Ngoc Tran V, Phung KL, Wolbers M, Whitehead SS, Hibberd ML, Wills B, Simmons CP. Nguyen TH, et al. PLoS Negl Trop Dis. 2013 Dec 12;7(12):e2592. doi: 10.1371/journal.pntd.0002592. eCollection 2013. PLoS Negl Trop Dis. 2013. PMID: 24349598 Free PMC article. Clinical Trial.
  • Corticosteroids for dengue infection.
    Zhang F, Kramer CV. Zhang F, et al. Cochrane Database Syst Rev. 2014 Jul 1;2014(7):CD003488. doi: 10.1002/14651858.CD003488.pub3. Cochrane Database Syst Rev. 2014. PMID: 24984082 Free PMC article. Review.
  • Effectiveness of corticosteroid in the treatment of dengue - A systemic review.
    Bandara SMR, Herath HMMTB. Bandara SMR, et al. Heliyon. 2018 Sep 22;4(9):e00816. doi: 10.1016/j.heliyon.2018.e00816. eCollection 2018 Sep. Heliyon. 2018. PMID: 30258999 Free PMC article. Review.

Publication types

LinkOut - more resources